AHF NCI Collection
Tobacco-Specific Nitrosamines; Occurrence, Formation, Carcinogenicity, and Metabolism
Fields
- Type
- Bibliography
- Chart/Graph
- Psci, Scientific Publication
- Named Organization
- AHF, American Health Foundation
- American Chemical Society
- Characteristic
- Marginalia
- Author
- Chen, C.B.
- Hecht, S.S.
- Hoffmann, D.
- Named Person
- Byland
- Fischer
- Keefer
- Lijinsky
- Millers
- Singer
- Spraguedawley
- Taylor
Document Images
lReprinted from ACCOUNTS OF CHEMICAL RESEARCH, 12,92 (1979).]
Copyright © 1979 by the American ChemicaliSucietp and reprinted by permission of the
cupyrightowner.
obacco-Specific Nitrosamines: "Occurrence, Formation,
Uarcinogenicity, and Metabolism
,STEPHEN S. HECHT,* CHI-HONG B. CHEN, and DIETRICH HOFFMANN
;. Division of Ent;ironmental Carcinogenesis, ><'aylor Dano Irzstilutr for Disease Pteuention,
American Health Foundation,
Valhalla, Neu, York 10595
Receiied April 17, 1978
It is now widely accepted that cigarette smoking is
causally associated with lung cancer.t' It is less widel.v
known that smoking is also correlated with an~ increased
incidence of cancer of the oral cavity,, esophagus,
pancreas, and bladder.'4 Tobacco chewing can also
cause oral cavity and esophageal cancer.3~4'" In fact,
cancer of the mouth is a major cancer among men in
India, where the habit of chewing the betel quid! con*
taining tobacco is widespread.8 Cigarette smoke is
known to contain tumor initiators, such as the poly-
nuclear aromatic hydrocarbons, and tumor promoters
and cocarcinogens, such as catechol.9' These agents can
explain many of the observed effects of cigarette smokee
condensates in experimental animals and most likely
are involved in some of the human cancers associated
Dietrich hloffmann is a member ot the American Heatah Foundation and'Chief,
of its Division of Environmental ICarcinogenesis. He received his B.S. and M.S:
degrees from the University of'Kieliand the Ph.D: from the IJlax Ptanck Institute
for Biochemistry, Munich;, Germany. He was an Associate Member of the
Sloan-Kettering Institute for Cancer Fesearch,
Stephen S. Heeht received the Phi.D: degree from Massachusetts Institute
- of Technology in 1968. He is an associate member of the American Health
Foundation. -
Chi-hong B. Chen is a research associate at the Foundation. She earned
her Ph D. degree from New York University.
- The investigators are Interested in the isolation: identification, and reduction
of carcinogens in materialsv,rtlich~.have been associated with human cancer,
as welli as in the metabolic activation of polynuclear aromatic hydrocarbons.
N-nitrosamirres, ottxr carcinogens, and the reaction of the active species of
carcinogens with cellular macromolecules. This paper is no. 17 in,the series
'A Study of Tobacco Carcinopenesis`.
with smoking. However, nitrosamines may also be
causative factors in the tobacco-related cancers, es-
pecially in those organs which are remote from direct
contact with tobacco or tobacco smoke. Thus it is
known that nitrosamines can cause esophageal, pan-
creas, and' bladder cancer in experimental animals as
well as affect the lung and oral cavityao-lz
Since the first report on the carcinogenicity of di-
methylnitrosamine,13 a wide variety of nitrosamines
have been tested in various experimental animals.1o,1<
(1) U.S. Department of Health, Education and Welfare: U.S: Publ.
H1th, Serv. Publ. tioi 1103; 196a; HEW Pub1i No. (HSM) 71-7513, 1971;,
DHE1N' Publ. No. (CDC) 76-8704 (1975).
(21 1t',vnder, E. L.: Stellman. S. D: Cancer Res. 1977, 37, 4608.
(3) Wynder, E. L.: Bross, 1. J.;,Feld'manR. M. Cancer 1957,,101300.
(4) \4'vnder, E. L.; Bross. I. J. Cancer 1961. 14, 389.
(5) Wynder, E. L.: Mabuchii K.; Maruchii N.: Fortner, J. G. J. Natl,
Cancer lnst: 1973. 50, 645.
(6) 11'ynder, E. L.: Goldsmith. R. Cancer 1977, -00, 1246.
(~~) \Tucve, G. E.: Bissinger, L. L.; Proehl. E. C. J. Am: Geriatr. Soc.
1953, 1; 497.
(8) Javant., K.;,Balakri.chnan4 V.; Sanghva,L. D.; Jussawa11a;,D. J, Brii.
J. Canc-er 1977, 35, 232.
(9) 1i'.nder, E., L.; Hoffmann, D. "Tobacco and Tobacco Smoke';
Academic Press: New York, 1967.
(101 Magee, P. N.; Montesano. R; PreussmannR ACS Monogr. 1976,
No. 173, 491. .
(11) Pour, P.; Althoff, J.; Krilger, F.; Schraahl. D.; Mohr. U. Cancer
Lert. 1975. 1, 3.
4
(1a Pour, P.; Althoff, J.; Nagel, D. Cancer Lett. 1977, 3,
109.
(13) Magee, P. N.; Barnes, J. M. Brit. J. Cancer 1956, 10, 11{.

1 1....1t.(.U lILLI Uu(L1JLl, L..
NNN
NICOTYRINE
ANABASINE ANATABINE BIPYRIDYL
Figure 1. Common tobacco alkaloids in tobacco and/or tobacco
smoke. .
Most nitrosamines with available hydrogens on~ the
carbons a to the nitrosamine nitrogen are carcinogenic.
Nitrosamines generally affect specific organs in a given
experimental animal, and the effect is often inde-
pendent of the route of administration. In animals`
generally used for bioassay the target organs are fre-
quently the esophagus and liver in the rat, the re-
spiratory tract in the Syrian golden hamster, and the
lungs and liver imthe mouse:10" However, other organs
such as pancreas and bladder are also affected by ni-
trosamines with particular structural characteris-
tics.1o,12.15
Because of the structural' diversity of nitrosamines
which can cause cancer in experimental animals and the
potency of many of these agents, their occurrence and!
formation in human environments have been studied'
intensively.10 Analytical methods are now available for
the routine determination of trace amounts of nitros-
amines. Important among these is the methodology
involving the "thermal energy analyzer" (TEA), a
sensitive and specific detector for nitrosamines, which
can be coupled to a gas or liquid chromatograph.l6' By
use of this technique and conventional analytical
methods, nitrosamines have been identified most
-commonly in processed meats, cheese, air pollution,,
unburned tobacco, mainstream and sidestream tobacco
smoke, cosmetics, and industrial cutting fluids.'1`21'
Concentrations are often in the parts per billion range,
although much higher levels of certain nitrosamines
(14) Druckrey, H.; Preussmann, R.; Ivankovic, S.; Schmahl;, D. 2.
Krebsforsch. 1967, 69, 103:
(15) Druckrey, H.;, Preussmann4 , R.; 1.ankovic, S:; Schmidt. C. H.;
Mennel, H. D.; Stab], K. W. Z. Krebsforsch. 1964, 66, 280.
(16) Fine, D.; Rufeh, F.; Lieb, D.;,Rounbehler, D. P.,Anal. Chem. 1975,
47, 1188.
(17) Sen, N. P. In "Toxic Constituents in Animal Foudstuffs";,Liener~
H. E., Ed.; Academic Press: New York, 1974,p 131.
(18), Fine, D. E; Rounbehler, D. P.; Pellizzari;, E. D.; Bunch, J. E.;
Berkley, R W:;,McCrae, J.; Bu~'sey, J. T.; Sawicki, E; Krost,lG; DeMarrai.s,
G. Bull. Environ. Contam. Toricol: 1976, 15, 739.
'(19) Brunnemann, K. D.; Yu+,L.; Hoffmann, D. Cancer Res. 1977, 37,
32I8.
(20)' Fan, T. Y.; Goff, U.; Song, L; Fine, D. H.; Arsenault, G. P.; Biernann;
K. Food Cosmet. Toxicol. 1977, 15, 423:
(21) Fan, T. Y.; Morrison, J.; Rounbehler, D P.; Ross, R Fine D H.;
;: itfiles, W.; Sen. N: P. Science 1977, 196, 70!
NPr NAB
9s
Figure 2. Some nitrosamines which can be derived from the
tobacco alkaloids.
have been found' in cosmetics, cutting fluids, tobacco,
and tobacco smoke. Nitrosamines are also formed in
vivo by nitrosation of amines. This route of exposure
is of particular concern since nitrite and amines are
widely distributed.22
Since tobacco and tobacco smoke have specific car-
cinogenic effects in man, one can hypothesize that there
may be unique carcinogenic agents in tobacco and
tobacco smoke. The tobacco-specific nitrosamines are
such a group. These nitrosamines are derived from the
tobacco alkaloids (see Figure 1). The most prevalent
alkaloid' is nicotine, which. occurs in general in con-
centrations of 1-2% in commercial tobacco products.
Both nicotine and nornicotine could give rise to the
prototype of tobacco-specific nitrosamines, N''-nitro-
sonornicotine (NNN). Nicotine could also be nitrosated
to form 4-(N-methyl-N! nitrosamino)-11-(3-pyridyl)-1-
butanone (NNK) or 4-(A'-methyl-N-nitrosamino)-4-
(3-pyridyl)butanal (NNA). In addition, N-nitroso-
pyrrolidine (NPy), which is formed during smoking,
could be d'erived' from nicotine and nornicotine.19
Nitrosation of anabasine would give nitrosoanabasine
(NAB). The structures of the nitrosamines whi&will
be considered in this Account are shown in Figure 2.
Of course, inspection of Figure 1 reveals other inter-
esting possibilities for nitrosation of the tobacco al-
kaloids; some of these possibilities are the subjects of
ongoing studies.
Occurrence and Formation of Tobacco-Specific
Nitrosamines
The prototype of the tobacco-specific nitrosamines,
NNN, has been detected in both tobacco smoke and
unburned tobacco. Various analytical methods have
been used, including gas chromatography (GLC),23-26
combined GLC-mass spectrometry,27 thin-layer chro-
matography,28 high-pressure liquid chromatography
(LC),'-` an& combined LC-thermal energy analysis.31'
(22) MirvishS. S. Toxico! Appl. Pharmocol. 197531, 325.
(23) Hoffmann, Di; Rathkamp, G.; Liu, Y. Y: Int. Ag. Res. Cancer Sti:
Pub'1: 1974, No. 9,159.
251 (24) Klus, H.; Kuhn, H. Fachliche Mitt. Oesterr. Tabakregie 1973,14,
.
(25) Hecht. S. S.; OrnafR: M.; Hoffmann, D. J. Notl: Cancer Inst.
1975. 541237. Also see note added'in proof.
(26) Bharadwaj, V P.; Takayama, S.; Yamada, T.; Tanimura, A. Gann
1976. 66; 585.
(2i) Munson, J. 11'.;:Abdine, H. Anal. Lett: 1977, 10, 777.
(28) hlus: H.; Kuhn4 H. Fachliche Mitt. 0esterr. Tabakregie 1975, 16,
307.
(29) Hecht, S. S.; Ornaf, R. M.; HoffmannD. Anal, Chem. 1975, 47,
2046. -
(30) Hoffmann, D.; Dong, M.; Hecht, S. S. J. Natl. Cancer Inst. 1977,
.58,1841.
(31) Brunnemann, K. D.; Adams, J.; Hoffmann D Abstr. Tob. Chem
R
C
3
on/
ex
/at Greensboro NC 1977: ~;~~
..,,,..,. 0,,,,4
~
_Apa~

FRESH HARVESTED NICOTINE NORNICOTINE
TOBACCO
NITRITE
CURED TOBACCO NICOTINE NNN NORNICOTINE
MAINSTREAM
CIGARETTE SMOKE
NITROGEN I
OXIDES
Figure 3. Origins of NNN in tobacco and tobacco smoke (tobacco
is known to contain nitrate and nitriteu),
NhTN' levels in the smoke of a typical American 85-mm
nonfilter cigarette range from 140 to 240 ng/cigarette.
Surprisingly high levels of NNNI were found in un-
burned tobacco (0.3-9.0 ppm in cigarette tobacco,
3.0-45.3 ppm in cigar tobacco, 3.5-90.6 ppm in chewing
tobacco, and 12.1-29.1 ppm in snuff). These levels are
among the highest for an environmental nitrosamine
in terms of occurrence and, human exposure.32 Thus,,
rather detailed studies were carried out to determine
the origins of NNN in tobacco and tobacco smoke.
To study the formation of NNN in tobacco, plants
were analyzed at various stages of growth and curing.33
NNN' was not detected prior to harvest or in freshly
harvested Burley tobacco but only during and after air
curing (0.5-1.1 ppm), which is the process normally
employed before use of Burley tobacco in market
-products. Since either nicotine or nornicotine could
have been a precursor to NNN in tobacco, tobacco
leaves were fed nicotine-2`-"C or nornicotine-2'-14C.34
The yield of NNN from nicotine was 0.009% and from
nornicotine, 0.007%. These results showed that both
nicotine and~ nornicotine could be precursors to NNN
in tobacco. However, the greater abundance of nicotine
in tobacco leaf (20-100 times the concentration of
nornicotine) favored nicotine as the major precursor of
NNN in tobacco.
The transfer of NNN from cigarette tobacco to
mainstream smoke was also studied.' For this purpose,
NNN-2'-"C was added to cigarettes and the smoke was
analyzed, The transfer rate was found to be 11.3%.
Since, in this experiment, the tobacco column smoked
contained 974 ng of NNN', 110 ng was transfered to the
mainstream smoke. Analysis of the mainstream smoke
revealed 238 ng of NNN; thus the remaining 12S'ng was
formed during smoking. Therefore,,about 50% of the
NNN in mainstream smoke originated byy transfer from
tobacco while the remainder was formed'' during
smoking,
Either nicotine or nornicotine could be a precursor
to NNN formed during smokinr. To examine this
question, nicotine or nornicotine was added to cigarettes
and the smoke was analyzed for NNN.=1 ' In each case,
NNN'' concentration in smoke increased, indicating that
(32)'Fine, D. H.14HO Cconference Proceedings 197S:1ARC Sci. PuhL
No: 19;, 267,
(33)' Hecht, S. S.; Chen. C. B.; Dong. M.; Ornaf, R. M.; Hoffmann. D.:
""Tso, T. C. f3eitr TobokJursch. 1977. 9, 1.
(34)' Hecht, S. S.; Chen, C. B.;,Ornaf; R. M.;,Hirota, N.: Hoffmann. D.;
Tso. T. C. J. Notl. Cancer In.ct. 1975, 60, 819.
from NNA
both alkaloids are precursors to NNN' formed during
smoking. However, nicotine is considered the more
important precursor due to its higher concentration in
tobacco. The results of these studies on the formation
of NNN during curing, its transfer to smoke, and its
formation during smoking are summarized in Figure 3.
In~ tobacco samples examined so far, the levels of
NAB are significantly less than those of NNN. In fact,
NAB has not yet been detected with certainty in un-
burned tobacco.5 These findings are in line with the
major role of nicotine rather than nornicotine as a
precursor to NNN since kinetic studies showed that
nornicotine and anabasine were nitrosated at similar
rates.3S The fact that these rates are relatively high
suggests that the formation of NNN and NAB could
be favored in vivo: When chewing tobacco was incu-
bated with human saliva for 3 h at 37 °C and the
mixture analyzed for NNN, the concentration,of NNN
increased~ by 44% over that in the chewing tobacco,,
presumably as a result of further nitrosation.25 Thus,
in vivo formation of NNN and NAB could constitute
an addit.ionali exposure of smokers or chewers to these
tobacco-specific nitrosamines.
Since nicotine is the major precursor to NNN in
tobacco and tobacco smoke, the reaction of nicotine
with sodium nitrite was studied to provide information
on formation of other tobacco-specific nitr~osamines,
especially. NNK and NNA, which coul6 arise by oxi-
dative cleavage of the; 1'-2' bond or 1'-5' bond of
nicotine followed b_v nitrosation.3e The reaction was
investigated under a variety of conditions. All three
nitrosamines were formed when the reaction was done
under relatively mild conditions (17 h,, 20 °Cl. The
yields (0.1-2.8%) were typicaL of those for formation
of nitrosamines from tert.iarvy amines.3' At 90 °C, with
a fivefold! excess of nitrite, only NNN and NNK were
detected. Under these conditionsboth NNK and NNA
-gave secondary products. NNK was nitrosated a to the
carbonyl to yield 4-(N-rnethyl-N-nitrosamino)-2-oxi-
mino-l-(3-pyridyl)-1-butanone (1),while NNA under-
went cyclization followed byy oxidat~iondecarboxylation,
and dehydration to give 1-methyl-5-(3-pyridyl)pyrazole
(2) as shown in Scheme I. Extensive fragmentation and
oxidation of the pyrrolidine ring were also observed
under these conditions. The major prodllcts.resulting
from fragmentation of the pyrrolidine ring were cis- and'
(35) ASirvish, S. S.; Sams, J.; Hecht. S. S. J. Natl. Cancer,lnst. 1977,
$9, 121'1.
(36) Hecht. S. S.; Chen, C. B.; Ornaf, R. M.; Jacobs, E.; Adams: J. D.;.
Hoffmann. D. J. Org. Chem, 1978, 43. 72.
(a7 ) Lijinsky; W.; Keefer, L.: Conrad. E:: van de Bnprd, R. J.:1'6d.
( irncer Inst. 197:. ./9, 1239.
Scheme I
Formation of 1-Methyl5-(3-pyridyl)pyrazole (2)

. va. ar., i./ I J
_,Na
a, No
NONO
1 uuu(.cu /vbcrUaurjtirbea
trarl..s-3-(3-pyridy,l)acrylonitrile and N-methylnicotin-
amide.
Z-:The formation of NNN, NNK, and NNA from riic-
I otine probably involves the intermediacy of cyclic
iminium salts, as shown in Scheme 11.38 These salts
.'can* undergo hydrolysis to the free amines which are
nitrosated, or, at near neutral pH, can~ be directly ni-
trosated to give nitrosamines. The formation~ of ni-
trosamines trosamines from iminium salts under neutral conditions
has been demonstrated in~at least two studies and is of
interest because iminium salts are known to be inter-
mediates in the mammalian metabolism of nico-
tine.36,39~'' The possibility that tobacco bacteria could
nitrosate nicotine via this pathway is currently under
investigation.
The formation of NNK and NNA from nicotine inn
these model'studies encouraged us to search for these
:. nitrosamines in tobacco and tobacco smoke. In studies
. undertaken so far, NNK, but not NNA, has been de-
tected. tected. NNK was most readily analyzed by combined
' LC-TEA, although conventional LC methods have also
been used.31-" Levels of NNN and NNK in tobacco and
mainstream cigarette smoke are summarized in Table
I. These data are significant because carcinogenicity
studies indicated activity for both NNK and NNN.
The analytical studies discussed in this section were all
done using NNN-2'-14C as internal standard. Tobacco
was extracted with~ aqueous ascorbic acid and smoke
was collected in traps containing ascorbic acid, to
prevent artefactual formation of nitrosamines.
Carcinogenicity of Tobacco-Specific -
Nitrosamines
The first studies on the carcinogenicity of NAB and
NNN were done by Boyland and' co-workers., who
demonstrated that"IvTAB caused esophageal tumors in
`(38) Smith, P. A. S.;,Loeppky, R: A1. J. Am. Chem. Soc: 1967.8R ,1147.
(89) Keefm L. K.; Roller, P. P. Science 1973, 181, 1245.
(40) Nguyen. T. L.; GruenkeL. D.; Castairnoli, N. J:11led.,Chem: 1976..
19 1168.
i& (41) I<furphy, P. J. J. Biol: Chem. 1973, 248, 2796,
.
Scheme II
Formation of Tobacco-Specific
Nitrosamines from Nicotine
Table I
NNN and NNK in Tobacco and Tobacco Smoke
95
mainstream, sidestream, tobacco,
ug/cig µg/cig ppm
product NNN NNK NNN 'NNK NNN NNK
Burley, NF 3.7 0.32 6.1 0.66 7.0 -
Bright, NF 0.62 0.42 1.7 0.50 0.22 0.37
commercial, 0.24 .0:111 1.7 0.41 1.7 0.74
NF
commercial, F 0.31 0.19 nd° nd 1.4 0.70
. Kentucky 0.39 0.16 nd nd .. 0.63 0.13 `
1R1, NF
little cigar, F 5.5 4.2 . 0.88 0.81 45.3 ' 35.4
large cigar, F 3.6 2.4 nd nd 5.0 2.2
Columbia cigar 3.2 1.9 16.6 15.7' , nd nd
° nd = not' determined.
rats and that NNN induced lung adenomas in mice.*zt3
In our own~ studies, the carcinogenicity of NNN and
NAB was first compared in Fischer rats:'" In the NNN
group, 14 of 20 animals developed esophageal tumors
after a total dose of 3.6 mmol/rat given in the drinking
water. By contrast, NAB at this dose gave only 2 of 20
tumor-bearing animals. NNN also induced'tumors of
the olfactory epithelium in Sprague-Dawley rats, as
demonstrated by Singer and Taylbr!s
The tumorigenic activities of NNN and NAB were
then compared in Syrian Golden hamsters.'6 . In this
experiment, NNN and NAB were each given by sub-
cutaneous injection, the total dose being 2 mmol/'
hamster. Within 83' weeks, 12 of 19 hamsters given~
NNN developed tumors of the trachea, which is a
typicaI target organ for nitrosamines in this species. No
tumors were observed in the animals treate&with NAB.
To compare NNN, NNK, and' NNA, bioassays were
done in strain A mice, whi& are unusuallv susceptible
to lung adenomas.'i The number of these tumors
observed in treated vs. control', groups can be used as
an~ indicator of carcinogenic activity. Each compound
was given i.n a total dose of 0.1 mmol/mouse. As judged
by multiplicityy of lung tumors, both NNN and NNK
showed significant activity (P < 0:05) compared to
controls, and NNTK was significantly more active (P <
0:0b) than NNN. NNA did not show significant tu-
morigenic activity. The greater tumorigenicity of NNK
and NNN in this strain of mice suggests potentially
higher carcinogenicityy in other rodent species; these
bioassays are currently in progress.
Metabolic Studies on NPy and NNN
Nitrosamines, like many other classes of chemical
carcinogens, must' undergo metabolic transformation to
be converted into reactive electrophilic species which
can alkvlate nucleophilic cellular macromolecules. This
process of metabolic activation has been studied ex-
tensively by the Millers, who were pioneers in devel-
oping these concepts. According to their scheme, an
inactive procarcinogen is metabolically transformed to
a proximate carcinogen and finally to an ultimate
carcinogen: the latter is a reactive electrophile su& as
(42) &ovland! E.; Rue;,F. J. C.: Gurrod. J. \C.: Mitchley, B. C. V. Brit.
J. Ca n c cr 1964. 23. 265.
(4fi1 Boyland. E.; Roe. F. Ji C.; Gorrod; J.11'. Nature (London) 1964,
202. 1126.
(441 Huffmann, D::Raineri. R.: Hecht. S. S.; Maronpot. R.;1tynder.
E. L. J. Narl: Concer Ina. 1975.5.5.977. . - ..
(45) Singer. G. M.: Ta>lur, H.11'. J. 1'atl. Cancer ln,ct. 1976. 37. 1275.
(461 Hilfrich. J.; Hecht, S. S.; Hnffmann. D. CanccrLett. 1977.2, 169.
I

' a carbonium ion.17 Such a scheme can be applied to
' dialkyl or cyclic nitrosamines in severali ways, and
~'various critical initial steps have been suggested4 in-
' -cludjng o ~hs droxylation, ~3-hydroxylation, and d-oxi-
-,,,,dation. Since the intermediates generated
~: metabolically may be unstable, indirect means have
' been used to gain evidence supporting the various
pathways. Most studies to date on both cyclic and
acyclic nitrosamines support the hypothesis that an
initial a-hydroxylation is a critical step in carcinogenesis
by nitrosamines. For cyclic nitrosaminessubstitution
at the a positions often results in decreased carcino-
genicity, as demonstrated in studies by Lijinsky, Keefer,
and Taylor. For example, 2,5-Me2NPy was significantly
less carcinogenic in the rat than an equimolar dose of
NPy.SO' Similar results were obtained with nitroso-
piperidlne-S1 Substitution of deuterium atoms a to the
nitrosamine function of nitrosomorpholine decreases
activity. Thus, 3,3,5,5-tetradeuterionitrosomorpholinee
was less carcinogenic than nitrosomorpholine.52 This
reduction in activity was consistent with the slower rate
of C-D bond breaking in a-hydroxylation of the deu-
terated compound!
Further information on the role of a-hydroxy-
nitrosamines as active intermediates in nitrosamine
carcinogenesis has been obtained in recent years by the
use of a-acetbxynitrosamines as model compounds.53:~t
Numerous a-acetoxynitrosamines have been synthes-
ized. and most, including 2-(Ac0)NPvwere mutagenic
in Solnlonel'la t~yphimurium without enzymatic acti-
vation.5:~-'° . In addition, meth.l(acetoxymethti1)-
nitrosamine and 1-acetoxvpropvlpropylnitrosamine
both showed primarily local carcinogenic effects in
experimental aniirla]s.6"°'-' These results are consistent
%~-ith the role of a-h}-droxylation in activation of di.
alkylnitrosamines. since in the presence of esterase, the
a-acetox~~~ compounds are readily hydrolyzed to the
corresponding a=hvdroxvnitrosamines.
Despite the apparent importance of a-hydrox~~lation
as an activation step for cyclic nitrosamines, limited
information was available on,metabolism of these
compounds b. this process.' This was due, in part.,
147) Miller. E. C.; Miller. J. A. .4CS Monu;r. 1976, 173:
(48) Kruger, F. W: In: "Prcicedings of the Second International
Symposium of the Princess Takamat.cu Cancer Research Fund", Nakahara.
W., Takayama, S., Sugimura, T.. and Odashima: S.. Eds.; Tokyo: Tokyo
Ptess. 1972, p 213.
(49) Schoental, R. Brit. J:,Concer 1973. 28, 436.
(50) Lijinsky, W.; Taylor, H. W. Cancer Res. 1976, 36. 1988.
(51) Lijinsky, W.; Taylor, H. Want. J. Cancer 1975. 16. 318.
(52)~Lijinsk.: W.; Ta.lor. H. 1t'.: Keefer. L. 1:. J. Nor1: Cancer Inrt.
19,6. 57.1311.
(53) RbllerP. P.; Shimp: D. R.: Keefer. L. K. Tctrahcdron Lett: 1975.
,
2065.
(Fial Wiessler, M. Angeu. Chem. 1974. ?A6.
61-.
(55) Tannenbaum. S. R.: Kraft. P.: Baldwin..J.: Branz. S. C'anrcr Lctt:
1977, 2, 305.
(56) Baldwin, J. E.; Branz. S. E.: Gomez. R. F.: Jiraft. P.: Sinske., A.
J.; TannenhaumS. R: Trlrchedrun Lctt. 19,6; 333.
(i7) Shuoter. K. V.; Wiessler. N1: Chem: Rir,L li7tcrcLr: 1y76. 14 . 1.
t58/ Okada. \i:; Suzuki'i E.: Takaku. a.: Atochizuki. AlI Gonn 1975. 66:
457.
/591 Camus, A. \3.;1t'iessler. \l.: Mala.eille. C.; Bartsch. H. 9futation
Res. 1978, 39; 187: ,r
(60) J1"ard. J. hi.; Rice. Ji W Roller. P. P.: Wenk, M. L. Cancer Res.
1977, 37. 3046.
(61) Wiessler, M.;,SchmahJ, D. Z. Krebb[urcch. 1976. S.i. 47.
(62) Althuff, J.; Grandjean. C.; Pour. P.;,Godd. B. Z. Anb.,fur.ch. 1977.
5(R, 127.
(63) Gtandjetn; C. J. J. \'atl: Cancer Ina. 1976. 57. lNl'
e-Hydroxylation of NPy°
Intermediates and Products Resulting from
Scheme III
`M~=OEi0!C \N `0'
5
N
1-N-
N"W
+;n 8 9 10
° Reproduced with permission from Cancer Research.°
to the inherentt instability of the a-hydroxynitros-
amines. In our studies on the metabolism of cyclic
nitrosamines. we have used model compounds to de-
terrnine the probable products of metabolic a-
hvdrox-Oation and have then searched for these
products as metabolites. In this way, metabolic a-
hYdroxvlation of NPy and'NNN was demonatrated.66-,E-'
'
The approach for NPy is outlined in Scheme III.
n-Hvdro.vlatiom of NPy ' would give 2-(HO)NPy (4)
which is expected to undergo spontaneous ring opening
to 3'-formvl-l-propanediazohvdroxide (6); this inter-
mediate would! lose I*1, and hvdroxide to give oxo-
carbonjum ion 7. This oxocarbonium ion could react
with cellular macromolecules as we10 as be trapped' by
water to give -1-hvdtox~.butvrald'ehvde (9), which exists
predorninantl\ as the cyclic hemiacetal. 2-h.ld'roxv-
tetxahydrofilran (10). To validate this scheme, 2-
(Ac0)NP\.'6 (3) and -1-(.N'-carbethoay-j\'-nitros-
amino)butanal (5) were s%-nthesized as precursors to the
unstable intermediates 4 and' 6. Hydrol~~sis of both 3
and 5 gave '?-h~drox~~tetrah~.drofuran (10) as the major
product. in support of the intermediacy of 4, 6, and' 7
(64) kruger. F. 1C;: Bertram. B.: Eisenbrand. G. Z. tirebF/ursch'. 1976,
125.
(6i1 Rugs. A. E.: Uinich. S. S. J. .\'arL Cancer Inst. 1977. 68, 651.
(luir Hecht: S. S.: Chen. C. B.; Hoffmann. D. Cancer Res, 191 8, 38.215.
.
(6'1 Chen. C. B.: Hecht. S. S.: HaffSnnnn_ D" Prur" Am. _a..ar- t'n.-
Rc.-: 1978. 1.9; 116.
(6Si Chen. C. B.: Hecht. S. S.; Hoffmann. D. Cancer Rec. 1978.38.3639.

Tobacco Nitrosamines
Scheme IV
Intermediates and Products Resulting from
c-Hydroxylation of NNN°
N0
r \
/NY/ \\.iYO
/M N7R0
. ° Reprinted .vith permission from Cancer Research.se
as shown in Scheme IIL Both 3 and 5 were mut.agenic
in S. typhimurium strains TA 100 and TA 1535without
enzymatic activations presumably because of in situ
hydrolysis to 4, 6, and 7.
Metabolic a-hydroxylation of NPy was then dem-
onstrated in vitro by isolation of 4-hydroxybutyr-
aldehyde 2,4-dinitrophenylh.drazone (8) after incu-
bation of NPy with liver microsomes. The formation
of 10 was also demonstrated in vivo b} isolation of 8
from the urine of rats injected wit.h, NPy.
Metabolic a-hv.droxylittion of the tobacco-specific
carcinogen NNN was studied using a similar approach.
Despite the apparent similarity of NNN and NPv. some
differences were apparent in the model and metabolic
studies. Scheme IV summarizes the main features of
these eaperiments..Both 2'-(AcO)NNN (11) and 5'-
(Ac0)NNN (14) were synthesized' as model precursors
to 2'-(HO)NNN (12) and 5'-(HO)NNN ('13). The
syntheses were done by procedures reported for 2-
(Ac0)NPy.'s Hydrolvsis of the 2'-acetate i l gave, as
.:>:; major products, myosmine (50-60%) and the keto
-~.alcohol 20 (5-10 70. The 5'-acetate 14 gave predomi-
nantlv the lacto122 (60-70%). Formation~of20 and 22
from the 2'-acetate and the 5'-acetate can be ration-
alized as shown in Scheme IV. However, the high yield'
of myosmine in the solvolysis of 11 and the rapid rate
of decomposition of 11 in~ H~0 (half-life at 37 °C = 10
min vs. 180 min for 14) indicated that loss of'OAc and
N0+ was a competing pathway to formation of 12.
Therefore. nitrosourethane 15 was also prepared' as a
model compound for the 2'-h~~~dro.ylation pathway.
Hydrolysis of 15 gave predominantly. 20.
When tested in S. typhrmurium TA 100, all three
model compounds were mutagenic without activation.
The ?'-acetate 11 was weakly mutagenic, the 5=acetate
14 was moderately mutagenic, and the nitrosourethane
15 was hinhih~ mutagenic. These differences in muta-
aenicity may be partially due to differing rates of hy-
drolvsis of"11, 13, and 15. When NNN was tested at
comparable doses in the presence of hepatic super-
natants, no sianificant activity was observed. However,
NNN was mutagenic at higher doses.
Evidence for metabolic c%-hvdroxvlation of NNN was
obtained in vitro or in vivo. When NIkN was incubated
with rat liver micrc,somes, t.he formation of 20 and 21
was demonst.rated hti isolatiun.'of the 2.4-dinitro~

~ phenylhydrazones 24 and 25. When rats were treated
_11~ with NNN, 73-85% of the dose was excreted in the
urine, but 20 and 21 were not detected. However,
.products of further oxidation of 20 and 21, the keto acid
~ 23, hydroxy acid 26, and lactone 27 were isolated. The
formation of 20 and 21 in vitro is most readily explained
by initial 2'-hydroxylation or 5'-hydroxylation of 1jNN,
.as indicated in Scheme IV. The metabolites 23, 26, and
27 were formed, at least partially, by metabolic oxi-
dation of 20 and 21. Pathways other than an initial
:` cr-hydroxylation of NTNN could have been involved in
-: the formation of 23, 26, and 27, which are also observed
'°~ in the metabolism of nicotine.69 .
The results of these in vitro and in vivo experiments
demonstrate that both NPy and NNN undergo met-
abolic a-hydroxylation in the rat. The mutagenicity
data discussed above are consistent with the involve-
ment of a-hydroxylation as the critical step in the
metabolic activation of NPy and NNN. Further evi-
dence on the role of R-hydroxylation in the activation
of these compounds is currently being sought. through
carcinogenicity studies of a-deuterated NNN deriva-
tives and through studies of the binding of NPy and
NNN to DNA and RNA of target tissues.
Prospects :- ~._; ,: .. : . °.. . . .
The results described in this review indicate that the
tobacco-specific, carcinogens, NNN and NNIi, may be
causative factors in the various cancers associated with '
tobacco usage. These nitrosamines are derived pre-
dominanth' from the major tobacco alkaluid. niccrtine,
by nitrosatiun during the curing and smoking of to-
bacco. Other tobacco alkaloids maN also be precursors
to carcinogenic nitrosamines. Since NNIN and NNK
form during curing, it is feasible to reduce their con-
centrations in tobacco by appropriate management of
169) Gorrod. J. %C.: Jemier. P. In: "Essa}s in Toxicology", Ha.es. \i'.
.1., Ed.; Vol. 6: Academic Press: New York. 1975. p 35.
the curing and related processes. Formation during
smoking can also be inhibited. The reduction of these
and related nitrosamines in tobacco and tobacco smoke
js one approach to reduce tobacco-related cancers.
" A second approach begins with an understanding of
the metabolic activation and detoxification of tobac-
co-specific nitrosamines. The enzymes that mediate '
these transformations can be induced or inhibited by
environmental modifiers. Such modifiers may increase
or decrease the carcinogenic effects of these nitros-
amines. NNN and NPy, as well as NNK, all undergo
metabolic a-hydroxylation which is a likely activation
process. Specific induction of a-hydroxylation could
lead to greater carcinogenic activity; the modifier
causing this would _act as a cocarcinogen. Similarly,
specific inhibition of a-hydroxylation could have a
protective effect against carcinogenesis by these ni-
trosamines. The identification of these modifiers
through metabolic studies and bioassays is important
for a more complete characterization of the causative
' factors in tobacco carcinogenesis and for the prevention
of tobacco-related cancer.
Note Added in Proof. Recently N'-nitrosoan-
atabine, another tobacco-specific N-nitrosamine, has
been identified in tobacco (0.6-13 ppm), cigarette smoke
(0.33-4.6 ug/cig), and cigarette sidestream smoke
(0.16-1.5 jug/cig).'° Data on tha carcinogenic activity
of this,nitrosamine are not yet. available. :-
This uork tra.d supparted b.National Cancer Institute Grants
No. 1-CR-.55666. C.-t-11123i6. and CA-?1393. S.S.H. is recipient
of .Vatiunal Cancer Institute Research Career Detelopntent
Auard No. 5KlyCAO0121. We are grateful to Dr. Edmond
La 1'uie fur mutagenicit. assals and to Dr. G. Darid ;I1cCoy for
hi>lpful discussions un the metabolism experiments in vitro. We
;;rcath appreciate the cooperation of Dr. T. C. Tso, USDA.
&Itstille. MD. for providing us tr.ith experimental tobacco
samples. i .
(70) Hoffmann. D.: et al.. submitted for publication.
